南米および中米の薬物動態サービス市場予測 2031 年まで - 地域分析 - 薬物タイプ (小分子、大分子、ワクチン)、サービス タイプ (前臨床 ADME およびヒト研究、PK/PD 分析およびレポート、投与シミュレーション、リスク分析など)、治療アプリケーション (腫瘍学、感染症、神経疾患、自己免疫疾患、婦人科疾患、心血管疾患、呼吸器疾患など)、およびエンド ユーザー (製薬およびバイオテクノロジー企業、契約研究機関など)
CROへの薬物動態サービスのアウトソーシングが南米および中米の薬物動態サービス市場を活性化
薬物動態サービスを契約研究機関（CRO）にアウトソーシングすると、医薬品メーカーやスポンサーにいくつかの利点がもたらされます。これらのサービスを選択することにより、コスト効率の高い運用が可能になります。さらに、柔軟な作業とコア業務の拡張性の向上に集中できると同時に、迅速な処理時間を達成できます。アウトソーシングにより、製薬会社は能力構築、コスト削減、データ管理の対策を実施しながら、製品の商品化に集中できます。新薬の発見プロセスは複雑であり、エラーや誤った結果が発生すると、多大なコストが発生し、プロセスが遅れる可能性があります。 CROは、薬物動態学などの分野の専門知識を持つ経験豊富な科学者や研究者を雇用しています。そのため、製薬会社はCROの専門知識を利用できるため、そのような熟練した労働力の雇用や育成のための追加トレーニングに投資する必要がなくなります。そのため、有望な候補薬を持ちながらリソースが限られている中小企業や、事業の多様化に取り組んでいる大企業は、組織化されたCROが提供する臨床研究サービスを選択しており、薬物動態サービス市場が強化されています。
南米および中米の薬物動態サービス市場の概要
ブラジルは臨床試験の主要な目的地です。Clinical Trials Arenaによると、2021年にブラジルは世界の臨床試験活動の1.7％を占めました。2022年7月、Boston CROは、ラテンアメリカでの分散型臨床試験配信モデルの実装に向けた第一歩として、リオデジャネイロに拠点を置くInstituto Brasil de Pesquisa Clinica（IBPClin）を買収しました。同社は、ブラジル12州で7,000人以上の参加者を対象に、業界主催の研究調査を160件以上実施したと主張している。IBPClinは南米最大の研究センターである。2020年3月、フィオクルス財団は、世界保健機関（WHO）が支援する臨床試験に投資することを約束し、新しい病院センターを建設した。この新しい病院は、ブラジルでフィオクルスが主導する連帯臨床試験の開催地となる予定だった。この取り組みは、保健省科学技術局の支援を受けてブラジル12州の18の病院で実施され、INI / フィオクルスが調整している。このように、臨床研究の発展のために講じられたこのような取り組みは、ブラジルの薬物動態サービス市場の成長を後押ししている。
南米および中米の薬物動態サービス市場の収益と2031年までの予測（百万米ドル）
南米および中米の薬物動態サービス市場のセグメンテーション
南米および中米の薬物動態サービス市場は、薬物の種類、サービスの種類、治療用途、エンドユーザー、および国に分類されています。
薬物の種類に基づいて、南米および中米の薬物動態サービス市場は、小分子、大分子、およびワクチンに分割されています。 小分子セグメントは2023年に最大の市場シェアを占めました。
サービスの種類に関しては、南米および中米の薬物動態サービス市場は、前臨床ADMEおよびヒト研究、PK / PD分析およびレポート、投与シミュレーション、リスク分析などに分類されています。 2023年には、前臨床ADMEおよびヒト研究セグメントが最大の市場シェアを占めました。
治療用途別に見ると、中南米の薬物動態サービス市場は、腫瘍学、感染症、神経疾患、自己免疫疾患、婦人科疾患、心血管疾患、呼吸器疾患、その他に分類されています。腫瘍学セグメントは2023年に最大の市場シェアを占めました。
エンドユーザー別に見ると、中南米の薬物動態サービス市場は、製薬およびバイオテクノロジー企業、契約研究機関、その他に分類されています。契約研究機関セグメントは2023年に最大の市場シェアを占めました。
国別に見ると、中南米の薬物動態サービス市場は、ブラジル、アルゼンチン、その他の中南米に分類されています。2023年には、ブラジルが中南米の薬物動態サービス市場シェアを独占しました。
Charles River Laboratories International Inc; Eurofins Scientific SE、Certara Inc.、Parexel International Corp、Thermo Fisher Scientific Inc.、Allucent、PACIFIC BIOLABS、および SGS SA は、南米および中米の薬物動態サービス市場で事業を展開している大手企業の一部です。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Pharmacokinetics Services Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Chronic and Infectious Diseases
4.1.2 Expanding Range of Application of Pharmacokinetic Studies
4.1.3 Outsourcing of Pharmacokinetics Services to CROs
4.2 Market Restraints
4.2.1 Limited Reach of Pharmacokinetics Service Providers in Emerging Countries
4.3 Market Opportunities
4.3.1 Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics
4.4 Future Trend
4.4.1 Increasing Adoption of Big Data Analytics in Pharmacokinetics Services
4.5 Impact of Drivers and Restraints:
5. Pharmacokinetics Services Market - South & Central America Analysis
5.1 South & Central America Pharmacokinetics Services Market Overview
5.2 South & Central America Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031
6. South & Central America Pharmacokinetics Services Market Analysis - by Drug Type
6.1 Overview
6.2 Small Molecule
6.2.1 Overview
6.2.2 Small Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Large Molecule
6.3.1 Overview
6.3.2 Large Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7. South & Central America Pharmacokinetics Services Market Analysis - by Service Type
7.1 Overview
7.2 Pre-Clinical ADME and Human Studies
7.2.1 Overview
7.2.2 Pre-Clinical ADME and Human Studies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.3 PK/PD Analysis and Reporting
7.3.1 Overview
7.3.2 PK/PD Analysis and Reporting: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Dosing Simulations
7.4.1 Overview
7.4.2 Dosing Simulations: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Risk Analysis
7.5.1 Overview
7.5.2 Risk Analysis: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8. South & Central America Pharmacokinetics Services Market Analysis - by Therapeutic Application
8.1 Oncology
8.1.1 Overview
8.1.2 Oncology: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Infectious Diseases
8.2.1 Overview
8.2.2 Infectious Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Neurological Disorders
8.3.1 Overview
8.3.2 Neurological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Autoimmune Diseases
8.4.1 Overview
8.4.2 Autoimmune Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Gynecological Disorders
8.5.1 Overview
8.5.2 Gynecological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Cardiovascular Diseases
8.6.1 Overview
8.6.2 Cardiovascular Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Respiratory Disorders
8.7.1 Overview
8.7.2 Respiratory Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9. South & Central America Pharmacokinetics Services Market Analysis - by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Contract Research Organization
9.2.1 Overview
9.2.2 Contract Research Organization: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10. South & Central America Pharmacokinetics Services Market - Country Analysis
10.1 South & Central America
10.1.1 South & Central America Pharmacokinetics Services Market Breakdown by Countries, 2023 and 2031 (%)
10.1.1.1 Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.3 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.1.4 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.1.5 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.1.6 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by End User
10.1.1.2 Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.3 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.2.4 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.2.5 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.2.6 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by End User
10.1.1.3 Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.3 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.3.4 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.3.5 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.3.6 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by End User
11. Company Profile
11.1 Charles River Laboratories International Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Eurofins Scientific SE
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Certara Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Parexel International Corp
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Thermo Fisher Scientific Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Allucent
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 PACIFIC BIOLABS
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 SGS SA
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms for Pharmacokinetic Services Market
?
List of Tables
Table 1. South & Central America Pharmacokinetics Services Market Segmentation
Table 2. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type
Table 3. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type
Table 4. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application
Table 5. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 6. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type
Table 7. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type
Table 8. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application
Table 9. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 10. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type
Table 11. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type
Table 12. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application
Table 13. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 14. Glossary of Terms
?
List of Figures
Figure 1. South & Central America Pharmacokinetics Services Market Segmentation, by Country
Figure 2. South & Central America Pharmacokinetics Services Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031
Figure 5. South & Central America Pharmacokinetics Services Market Share (%) - by Drug Type (2023 and 2031)
Figure 6. Small Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Large Molecule: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Vaccines: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. South & Central America Pharmacokinetics Services Market Share (%) - by Service Type (2023 and 2031)
Figure 10. Pre-Clinical ADME and Human Studies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. PK/PD Analysis and Reporting: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Dosing Simulations: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Risk Analysis: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. South & Central America Pharmacokinetics Services Market Share (%) - by Therapeutic Application (2023 and 2031)
Figure 16. Oncology: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Infectious Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Neurological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Autoimmune Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Gynecological Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Cardiovascular Diseases: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Respiratory Disorders: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. South & Central America Pharmacokinetics Services Market Share (%) - by End User (2023 and 2031)
Figure 25. Pharmaceutical and Biotechnology Companies: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 26. Contract Research Organization: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Others: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. South & Central America Pharmacokinetics Services Market by Key Countries - Revenue (2023) (US$ Million)
Figure 29. Brazil: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Argentina: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of South & Central America: South & Central America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
- Charles River Laboratories International Inc
- Eurofins Scientific SE
- Certara Inc.
- Parexel International Corp
- Thermo Fisher Scientific Inc.
- Allucent
- PACIFIC BIOLABS
- SGS SA
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America pharmacokinetics services market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America pharmacokinetics services market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America pharmacokinetics services market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.